Women with a history of unilateral BC (survivors) have an increased risk of contralateral BC, ranging from about 40–44% (BRCA1 variant) and 26–33.5% (BRCA2 variant) [1, 3]. This evidence concerns the gene BRCA2 and breast cancer.